Thursday, April 20, 2023

COVID-19 vaccine hesitancy, local trust and local studies

Pokee N, Yasri R. Long term follow-up of pediatric cases with neurocysticercosis who received long-term albendazole therapy. Adv Trop Med Pub Health Int. 2023; 13: 3 - 4. ABSTRACT In this short letter, the authors provide data on a long term follow-up of 13 cases of pediatric cases with neurocysticercosis who received long-term albendazole therapy. The long-term albendazole therapy is proven effective and safe. Also, the cessation of drug after being adult is also proven a valid practice.

ong term follow-up of pediatric cases with neurocysticercosis who received long-term albendazole therapy

Pokee N, Yasri R. Long term follow-up of pediatric cases with neurocysticercosis who received long-term albendazole therapy. Adv Trop Med Pub Health Int. 2023; 13: 3 - 4. ABSTRACT In this short letter, the authors provide data on a long term follow-up of 13 cases of pediatric cases with neurocysticercosis who received long-term albendazole therapy. The long-term albendazole therapy is proven effective and safe. Also, the cessation of drug after being adult is also proven a valid practice.

Langya henipavirus: the newest zoonotic virus threat

Pokee N, Zhao R. Langya henipavirus: the newest zoonotic virus threat. Adv Trop Med Pub Health Int. 2023; 13: 5 - 6. ABSTRACT In this short letter, the authors provide data on a new emerging infectious disease, Langya heniparvirus infection. The zoonosis possibility is discussed. The disease is a new public health problem to be concerned. Key words: Langya henipavirus, emerging, zoonosis